Division of Neonatology, Department of Neonatal and Paediatric Intensive Care, Erasmus MC University Medical Center, Rotterdam, the Netherlands.
Division of Neonatology, Department of Paediatrics, Leiden University Medical Center, Leiden, the Netherlands.
Trials. 2024 Mar 20;25(1):198. doi: 10.1186/s13063-024-08027-7.
Infants born with congenital diaphragmatic hernia (CDH) are at high risk of respiratory insufficiency and pulmonary hypertension. Routine practice includes immediate clamping of the umbilical cord and endotracheal intubation. Experimental animal studies suggest that clamping the umbilical cord guided by physiological changes and after the lungs have been aerated, named physiological-based cord clamping (PBCC), could enhance the fetal-to-neonatal transition in CDH. We describe the statistical analysis plan for the clinical trial evaluating the effects of PBCC versus immediate cord clamping on pulmonary hypertension in infants with CDH (PinC trial).
The PinC trial is a multicentre, randomised controlled trial in infants with isolated left-sided CDH, born ≥ 35.0 weeks of gestation. The primary outcome is the incidence of pulmonary hypertension in the first 24 h after birth. Maternal outcomes include estimated maternal blood loss. Neonatal secondary outcomes include mortality before discharge, extracorporeal membrane oxygenation therapy, and number of days of mechanical ventilation. Infants are 1:1 randomised to either PBCC or immediate cord clamping using variable random permutated block sizes (4-8), stratified by treatment centre and estimated severity of pulmonary hypoplasia (i.e. mild/moderate/severe). At least 140 infants are needed to detect a relative reduction in pulmonary hypertension by one third, with 80% power and 0.05 significance level. A chi-square test will be used to evaluate the hypothesis that PBCC decreases the occurrence of pulmonary hypertension. This plan is written and submitted without knowledge of the collected data. The trial has been ethically approved.
ClinicalTrials.gov NCT04373902 (registered April 2020).
患有先天性膈疝 (CDH) 的婴儿有发生呼吸功能不全和肺动脉高压的高风险。常规做法包括立即结扎脐带和气管插管。实验动物研究表明,根据生理变化和肺部充气后,对脐带进行结扎(称为生理性脐带结扎)可以增强 CDH 胎儿向新生儿的过渡。我们描述了评估生理性脐带结扎与立即脐带结扎对 CDH 婴儿肺动脉高压影响的临床试验(PinC 试验)的统计分析计划。
PinC 试验是一项多中心、随机对照试验,纳入≥35.0 孕周、孤立性左侧 CDH 婴儿。主要结局是出生后 24 小时内肺动脉高压的发生率。母体结局包括估计的母体失血量。新生儿次要结局包括出院前死亡率、体外膜氧合治疗和机械通气天数。婴儿以 1:1 的比例随机分为生理性脐带结扎或立即脐带结扎,采用可变随机区组大小(4-8),按治疗中心和估计的肺发育不全严重程度(即轻度/中度/重度)分层。需要至少 140 例婴儿来检测肺动脉高压相对减少三分之一的情况,具有 80%的效能和 0.05 的显著性水平。将使用卡方检验来评估 PBCC 降低肺动脉高压发生率的假设。本计划是在不了解已收集数据的情况下编写和提交的。该试验已获得伦理批准。
ClinicalTrials.gov NCT04373902(2020 年 4 月注册)。